In particular, elevation of the serum fucosylated fraction of alpha-fetoprotein (AFP-L3) level before treatment is a predictor of HCC recurrence, and sustained elevation of the AFP-L3 level after treatment is an indicator of HCC recurrence [25]. The gene discussed is AFP; the disease is hepatocellular carcinoma.